Characteristics ofStreptococcus pneumoniaeand Atypical Bacterial Infections in Children 2–5 Years of Age with Community‐Acquired Pneumonia
Author(s) -
Susanna Esposito,
Samantha Bosis,
Roberta Cavagna,
N. Faelli,
Enrica Begliatti,
Paola Marchisio,
Francesco Blasi,
Ciro Bianchi,
Nicola Principi
Publication year - 2002
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/344191
Subject(s) - streptococcus pneumoniae , medicine , community acquired pneumonia , pneumonia , etiology , bacterial pneumonia , immunology , atypical pneumonia , pneumococcal infections , white blood cell , antibiotics , microbiology and biotechnology , biology
The characteristics of community-acquired pneumonia associated with Streptococcus pneumoniae infection were compared with those associated with atypical bacterial infection and with mixed S. pneumoniae-atypical bacterial infection in 196 children aged 2-5 years. S. pneumoniae infections were diagnosed in 48 patients (24.5%); atypical bacterial infections, in 46 (23.5%); and mixed infections, in 16 (8.2%). Although white blood cell counts and C-reactive protein levels were higher in patients with pneumococcal infections, no other clinical, laboratory, or radiographic characteristic was significantly correlated with the different etiologic diagnoses. There was no significant difference in the efficacy of the different treatment regimens followed by children with S. pneumoniae infection, whereas clinical failure occurred significantly more frequently among children with atypical bacterial or mixed infection who were not treated with a macrolide. This study shows the major role of both S. pneumoniae and atypical bacteria in the development of community-acquired pneumonia in young children, the limited role of clinical, laboratory, and radiological features in predicting etiology, and the importance of the use of adequate antimicrobial agents for treatment.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom